| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
563,448 | 450,088 | 371,304 | 328,199 | 293,563 |
| Cost of Revenue
|
-291,570 | -249,858 | -196,899 | -175,547 | -155,502 |
|
Gross Profit
|
271,878 | 200,230 | 174,405 | 152,652 | 138,061 |
| Selling, General and Administrative Expenses
|
-144,828 | -124,109 | -99,349 | -83,693 | -88,624 |
|
Research and Development Expenses
|
-38,983 | -28,984 | -23,304 | -17,549 | -14,755 |
| Depreciation, Amortization and Depletion
|
-56,777 | -49,487 | -44,355 | -45,040 | -51,742 |
|
Operating Income/Expenses
|
-240,588 | -202,580 | -167,008 | -146,282 | -155,121 |
|
Total Operating Profit/Loss
|
31,290 | -2,350 | 7,397 | 6,370 | -17,060 |
| Total Net Finance Income/Expense
|
-6,448 | -4,216 | 1,187 | 87 | 4,032 |
| Net Investment Income
|
-411 | -485 | -15,629 | -25,393 | -13,235 |
| Irregular Income/Expenses
|
-10,472 | 2,621 | 9,226 | -5,957 | -21,722 |
|
Other Income/Expense, Non-Operating
|
4,481 | -2,272 | -129 | 2,905 | 4,025 |
|
Non-Operating Income/Expenses, Total
|
-12,850 | -4,352 | -5,345 | -28,358 | -26,900 |
|
Pretax Income
|
18,440 | -6,702 | 2,052 | -21,988 | -43,960 |
| Provision for Income Tax
|
-2,458 | 1,328 | 2,280 | 5,153 | 14,068 |
|
Net Income from Continuing Operations
|
15,982 | -5,374 | 4,332 | -16,835 | -29,892 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
15,982 | -5,374 | 4,332 | -16,835 | -29,892 |
|
Net Income after Non-Controlling/Minority Interests
|
15,982 | -5,374 | 4,332 | -16,835 | -29,892 |
|
Net Income Available to Common Stockholders
|
15,982 | -5,374 | 4,332 | -16,835 | -29,892 |
|
Diluted Net Income Available to Common Stockholders
|
15,982 | -5,374 | 4,332 | -16,835 | -29,892 |
| Basic EPS
|
0.16 | -0.05 | 0.04 | -0.16 | -0.26 |
| Diluted EPS
|
0.16 | -0.05 | 0.04 | -0.16 | -0.26 |
|
Basic Weighted Average Shares Outstanding
|
98,556.27 | 99,566.53 | 101,040.58 | 107,465.98 | 114,890.25 |
|
Diluted Weighted Average Shares Outstanding
|
99,525.93 | 99,566.53 | 101,436.90 | 107,465.98 | 114,890.25 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
24,888 | -2,486 | 865 | -22,075 | -47,992 |
|
EBITDA
|
87,331 | 54,083 | 53,974 | 28,322 | 14,629 |
|
Normalized EBITDA
|
110,085 | 65,621 | 57,724 | 64,459 | 71,114 |
|
Normalized Income
|
35,702.96 | 3,879.48 | 7,107.75 | 10,845.94 | 8,517.80 |
|
Total Unusual Items
|
22,754 | 11,538 | 3,750 | 36,137 | 56,485 |
12/31/2022 - 3/3/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade